Your session is about to expire
← Back to Search
Shared Decision Making Tools for Kidney Transplantation
N/A
Waitlist Available
Led By Sumit Mohan, MD, MPH
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Receiving hemodialysis at one of the following dialysis clinics: Fresenius Kidney Care City Dialysis, DaVita Kidney Care Haven Dialysis, DaVita Melrose Dialysis, DaVita Highbridge Dialysis, Rogosin Institute East Side Dialysis Unit, Rogosin Institute West Side Dialysis Unit
Be older than 18 years old
Must not have
Younger than 18 years of age
Speaking a language other than English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of intervention/at completion of letter delivery (4-6 months)
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to empower kidney patients to make informed decisions about transplant & reduce inequalities in access to transplants.
Who is the study for?
This trial is for adults on hemodialysis at select clinics in New York and Cleveland who are either on a kidney transplant waitlist or undergoing evaluation at CU/NYPH Transplant Center or the Cleveland Clinic. Participants must speak English or Spanish.
What is being tested?
The study aims to improve kidney transplantation rates by using educational materials to enhance decision-making between patients and providers over a period of 6-12 months, focusing also on reducing disparities in access.
What are the potential side effects?
Since this trial involves patient letters and provider educational materials rather than medical treatments, there are no direct physical side effects associated with the interventions being tested.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am undergoing hemodialysis at a specified clinic.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am under 18 years old.
Select...
I speak a language other than English or Spanish.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ end of intervention/at completion of letter delivery (4-6 months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of intervention/at completion of letter delivery (4-6 months)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in donor kidney preferences
Change in frequency of shared decision-making conversations
Change in patient knowledge of individual waitlist status
Secondary study objectives
Change in dialysis provider attitudes, as measured on provider survey
Provider assessment of patient letters, as measured on provider survey
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: ProvidersExperimental Treatment1 Intervention
Dialysis providers will receive educational material about the kidney transplantation and waitlisting process.
Group II: PatientsExperimental Treatment1 Intervention
Dialysis patients will receive letters with information about their status within the kidney transplantation and waitlisting process.
Find a Location
Who is running the clinical trial?
National Kidney FoundationOTHER
31 Previous Clinical Trials
84,996 Total Patients Enrolled
1 Trials studying Kidney Failure
1,200 Patients Enrolled for Kidney Failure
Columbia UniversityLead Sponsor
1,498 Previous Clinical Trials
2,768,531 Total Patients Enrolled
Kidney Transplant CollaborativeUNKNOWN
Sumit Mohan, MD, MPHPrincipal InvestigatorColumbia University